china peptides retatrutide People are buying unregulated, injectable from Chinese factories. Are they safe? China Retatrutide (50mg) Factory -
Description
The first GLP-2 analogue (teduglutide) was approved for clinical use in the treatment of short bowel syndrome in 2012
doi: 10.1136/bmjdrc-2022-003218
Findings The study included 484,467 individuals with AID who were eligible for anti-obesity medication therapy
This means the dosage chart is not a temporary treatment plan
Ongoing Monitoring Post-Approval: After approval, the FDA continues to monitor the drug through post-market surveillance
V., Wong, W
